Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.07.016Source: DataRank Database

INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia is a research paper published in Transplantation and Cellular Therapy (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.25)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Elad Jacoby ORCID,Michael A. Pulsipher ORCID,Marcelo C. Pasquini ORCID,Stephan A. Grupp ORCID,Nirali N. Shah ORCID

Live enrichment

PubMed:37481241 PMC:PMC11031134 OpenAlex:https://openalex.org/W4384938026

National Institutes of Health

Grant: UG1 HL069254

NCI NIH HHS

Grant: P30 CA008748

NCI NIH HHS

Grant: K08 CA277013

Intramural NIH HHS

Grant: ZIA BC011823

National Cancer Institute

St. Baldrick's Foundation

FWCI

1.25

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

greenLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11031134/pdf/nihms-1919260.pdf

publisherhttps://api.elsevier.com/content/article/PII:S2666636723014203?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636723014203?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11031134

Fields of Study

CAR-T cell therapy researchHumansChildYoung AdultReceptors, Chimeric AntigenReceptors, Antigen, T-CellAntigens, CD19Retrospective StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaPrecursor B-Cell Lymphoblastic Leukemia-LymphomaBurkitt LymphomaT-LymphocytesMulticenter Studies as Topic

MeSH Terms

Receptors, Chimeric AntigenBurkitt LymphomaChildHumansReceptors, Antigen, T-CellRetrospective StudiesT-LymphocytesMulticenter Studies as TopicPrecursor B-Cell Lymphoblastic Leukemia-LymphomaAntigens, CD19Precursor Cell Lymphoblastic Leukemia-LymphomaYoung Adult

Keywords

Chimeric antigen receptorBlinatumomabMedicineClinical trialOncologyCD19AntigenImmunologyInternal medicineImmunotherapyCancerB-allPediatric LeukemiaCar T Cell

Sustainable Development Goals

SDG 0: Partnerships for the goals